Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc.
about
TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer.Appearance of Acute Myelogenous Leukemia (AML) in a Patient with Breast Cancer after Adjuvant Chemotherapy: Case Report and Review of the LiteratureNovel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinoma.E3 Ligase SCFβTrCP-induced DYRK1A Protein Degradation Is Essential for Cell Cycle Progression in HEK293 Cells.Overexpression of Lhx8 inhibits cell proliferation and induces cell cycle arrest in PC12 cell line.Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways.Dual-specificity tyrosine-phosphorylation regulated kinase 1A Gene Transcription is regulated by Myocyte Enhancer Factor 2DDyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.CLK2 blockade modulates alternative splicing compromising MYC-driven breast tumors.
P2860
Q33807765-41C24C27-BE09-475F-A0AF-44AC0F310F52Q35543798-CBD47A14-619B-407E-91B6-0019853A841FQ35554311-3440C7D4-A044-4C5B-8DC7-1C09E36D5DA4Q35640834-5BD69974-0734-4318-9B81-4594EF927D00Q37379468-A8083C5C-65B3-4607-9726-BFC08BB44ED0Q37395835-661E3A45-245B-4A77-97EE-51BB5B9670C6Q37507511-1EB4DEAA-D150-4644-8095-BBF5D6D35709Q38932247-6814663F-6AE1-451F-BD07-50DA3A814752Q40498643-0C5F85E4-485C-4FCC-B6BD-5AD97B814B81Q41242822-CEE9C387-F217-4114-A766-BDB6EBD4830CQ54201365-BFE39646-0196-483B-9BAC-55E0CD7B3C4BQ54978916-4980FE8C-299C-43DE-875F-36FD2CAB96A1Q55381826-990924E9-74CD-467B-A7D0-05EDCEEC14DA
P2860
Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tumor suppressor DYRK1A effect ...... cells by downregulating c-Myc.
@ast
Tumor suppressor DYRK1A effect ...... cells by downregulating c-Myc.
@en
type
label
Tumor suppressor DYRK1A effect ...... cells by downregulating c-Myc.
@ast
Tumor suppressor DYRK1A effect ...... cells by downregulating c-Myc.
@en
prefLabel
Tumor suppressor DYRK1A effect ...... cells by downregulating c-Myc.
@ast
Tumor suppressor DYRK1A effect ...... cells by downregulating c-Myc.
@en
P2093
P2860
P1433
P1476
Tumor suppressor DYRK1A effect ...... cells by downregulating c-Myc.
@en
P2093
Chunyan Ji
Shaolei Zang
Xiulian Sun
P2860
P304
P356
10.1371/JOURNAL.PONE.0098853
P407
P577
2014-06-05T00:00:00Z